# Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021

> **NCT05089942** · PHASE4 · UNKNOWN · sponsor: **Zhejiang Provincial People's Hospital** · enrollment: 16 (estimated)

## Conditions studied

- type1diabetes
- Type2 Diabetes

## Interventions

- **DRUG:** Recombinant Human Insulin Patch ZJSRM2021
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05089942
- **Lead sponsor:** Zhejiang Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12
- **Primary completion:** 2021-12
- **Final completion:** 2022-12
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05089942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05089942, "Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05089942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*